Video

PART 2: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillation - Trials and the Differences

Published: 21 May 2020

  • Views:

    Views Icon 58
  • Likes:

    Heart Icon 0

Prof Jan Steffel (Univerity Heart Center, Zurich, CH), Prof Jur ten Berg (St Anthonius Hospital, Nieuwegein, NL) and Prof Stefan Hohnloser (JW Goethe University, Frankfurt, DE) discuss Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillation - trials and the differences. 

This discussion was funded by an unrestricted educational service from Boehringer Ingelheim